2018
DOI: 10.1016/j.molbiopara.2018.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Leishmania donovani PP2C: Kinetics, structural attributes and in vitro immune response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
8
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 55 publications
1
8
0
Order By: Relevance
“…For example, purified LdPP2C is enzymatically active, and according to an inhibition study, sanguinarine likely acts as a non-competitive inhibitor (at pH 3.5-8.5). The molecular weight of the purified protein was 45 kDa (Jakkula et al, 2018). LcPP2C was reported to have a molecular weight of 42 kDa in both the infective promastigotes and the tissue amastigotes of L. chagasi and L. amazonensis.…”
Section: Discussionmentioning
confidence: 96%
See 3 more Smart Citations
“…For example, purified LdPP2C is enzymatically active, and according to an inhibition study, sanguinarine likely acts as a non-competitive inhibitor (at pH 3.5-8.5). The molecular weight of the purified protein was 45 kDa (Jakkula et al, 2018). LcPP2C was reported to have a molecular weight of 42 kDa in both the infective promastigotes and the tissue amastigotes of L. chagasi and L. amazonensis.…”
Section: Discussionmentioning
confidence: 96%
“…PP2C protein phosphatases have been characterized in Leishmania, including the PP2C of L. chagasi (LcPP2C), L. major (LmPP2C) and L. donovani (LdPP2C), (Burns et al, 1993;Escalona-Montaño et al, 2017;Jakkula et al, 2018). These enzymes share very similar biochemical characteristics.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Different STPs expressed by Leishmania parasites have been identified and characterized by biochemical and molecular means, including protein phosphatase 5 (PP5) (Norris-Mullins et al, 2018), protein phosphatase 1 (PP1) (Qureshi et al, 2019), protein phosphatase 2C (PP2C) (Jakkula et al, 2018), and protein phosphatase 2B (PP2B) (Banerjee et al, 1999) of Leishmania donovani; PP2B (Naderer et al, 2011), protein phosphatase with EF-Hand (PPEF) (Mills et al, 2007), and arsenate reductase 2 (ACR2) (Zhou et al, 2004;Zhou et al, 2006) of Leishmania major; PP2C (Escalona-Montaño et al, 2016) of Leishmania mexicana; and PP2C (Burns et al, 1993) of Leishmania chagasi.…”
Section: Introductionmentioning
confidence: 99%